Local Progression or Metastatic Melanoma With Failed First-line Treatment
1 clinical trials · Condition
◉ Watch Local Progression or Metastatic Melanoma With Failed First-line Treatment
| Record | Firm | Date |
|---|---|---|
| Phase Ib/II Clinical Study of Pexa-Vec (Vaccinia GM CSF / Thymidine Kinase-Deactivated Virus) Combined With Recombinant Whole Human Anti-PD-L1 Monoclonal Antibody (ZKAB001) in Metastatic Melanoma (NCT04849260) | Lee's Pharmaceutical Limited | 2021-08-26 |
Track Local Progression or Metastatic Melanoma With Failed First-line Treatment automatically
Every clearance here is in the API, with alerts when new ones post.